查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1810934

2025年全球白血球分离设备市场报告

Leukapheresis Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年白血球分离设备市场将强劲成长，到2029年将达到9.4亿美元，复合年增长率为7.5%。预测期内的成长动力包括：血液相关疾病盛行率上升、癌症发生率上升、週边血干细胞采集需求成长、白血球分离术（白血球输血）在细胞治疗中的应用不断扩大，以及再生医学和免疫治疗领域的投资不断增加。预计这段时期的主要趋势包括：分离设备的技术创新、自动化与数位技术的融合、床旁白细胞分离系统的进步、闭合迴路分离技术的进步以及细胞分离效率的技术提升。

血液相关疾病的日益普及预计将推动白血球分离设备市场的成长。这些疾病会影响血球的结构和功能，导致氧气运输、免疫功能和血液凝固等併发症。导致这一增长的主要原因之一是人口老化，他们更容易患上贫血、白血病和其他血液系统疾病。白血球分离设备在管理这些疾病方面发挥关键作用，它透过选择性地从血液中去除多余或异常的白血球，从而缓解症状并降低白血病和自体免疫疾病等疾病併发症的风险。例如，2024年5月，澳洲非营利组织白血病基金会报告称，2022年约有19,403名澳洲人被诊断出患有血癌，包括白血病、淋巴瘤和骨髓瘤。这相当于每天新增约53例，即每27分钟新增一例。目前，约有 135,000 名澳洲人正在与血癌和血病作斗争，预计到 2035 年将超过 275,000。血液相关疾病的成长趋势极大地促进了对白血球分离设备的需求不断增长。

白血球分离设备市场的主要企业正在增加对本地生产能力的投资，以改善治疗设备的可及性，并配合国家医疗保健策略。建立本地製造设施有助于简化供应链，减少对进口的依赖，并提高先进血液和细胞采集系统的价格可负担性和可用性。例如，2024年11月，美国医疗技术公司Terumo Corporation血液与细胞技术公司与其中国子公司Terumo Corporation医疗产品（杭州）有限公司合作，在杭州启动本地生产。该倡议专注于生产关键的白血球分离（白血球输血）产品，例如Trima Accel自动采血系统和Spectra Optia血液分离系统，这些产品在中国广泛应用于治疗性血液分离、干细胞采集和血液成分分离等程序。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球白血球分离设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球白血球分离设备市场：成长率分析
  • 全球白血球分离设备市场表现：规模与成长，2019-2024
  • 全球白血球分离设备市场预测：规模与成长，2024-2029年，2034年
  • 全球白血球分离设备：总目标市场（TAM）

第六章 市场细分

  • 全球白血球分离设备市场：按设备类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗性分离术
  • 血球耗竭疗法
  • 干细胞采集
  • 调查应用
  • 白血球分离柱和细胞分离器
  • 白血球分离术一次性用品
  • 血液分离机
  • 全球白血球分离设备市场：按组件、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 白血球分离装置
  • 采血套装
  • 医疗耗材
  • 筛选
  • 全球白血球分离设备市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 学术研究机构
  • 製药和生物技术公司
  • 血液成分供应商
  • 血液中心
  • 全球白血球分离设备市场：依治疗性分离术细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 白血病治疗系统
  • 败血症治疗白血球分离术科
  • 自体免疫疾病管理设备
  • 全球白血球分离设备市场：依血球去除疗法（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血小板成分采集装置
  • 淋巴单采单元
  • 红血球成分分析系统
  • 全球白血球分离设备市场：依干细胞采集类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 週边血干细胞（PBSC）采集装置
  • 脐带血采集系统
  • 骨髓干细胞单采系统
  • 全球白血球分离设备市场：按应用（类型）细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 用于研发的细胞分离系统
  • 临床试验血液分离平台
  • 学术实验室白血球分离装置
  • 全球白血球分离设备市场：按白血球分离柱和细胞分离器（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 吸附柱
  • 基于膜的细胞分离系统
  • 离心细胞分离器
  • 全球白血球分离设备市场：细分：白血球分离一次性用品（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 管组
  • 针头和导管
  • 收集袋
  • 全球白血球分离设备市场：按分离设备类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 常规流式血液分离装置
  • 可携式或移动式血液分离装置
  • 间歇流血液分离系统

第七章 区域和国家分析

  • 全球白血球分离设备市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球白血球分离设备市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 白血球分离设备市场：竞争格局
  • 白血球分离设备市场：公司简介
    • Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Grifols SA Overview, Products and Services, Strategy and Financial Analysis
    • TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Kaneka Corporation
  • Charles River Laboratories International Inc.
  • Mallinckrodt Pharmaceuticals
  • Nikkiso Co. Ltd.
  • Haemonetics Corporation
  • Miltenyi Biotec GmbH
  • Macopharma
  • Precision for Medicine Inc.
  • B. Braun Melsungen AG
  • BioIVT LLC
  • AllCells LLC
  • Kawasumi Laboratories Inc.
  • Beijing Zksk Technology Co. Ltd.
  • Puriblood Medical Co. Ltd
  • Medica SpA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年白血球分离设备市场：提供新机会的国家
  • 2029 年白血球分离设备市场：细分市场带来新机会
  • 2029 年白血球分离设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37036

A leukapheresis device is a specialized medical tool designed to selectively isolate and collect white blood cells (leukocytes) from the blood of a patient or donor through centrifugation or filtration methods. It serves an essential function in therapies such as leukemia treatment, stem cell transplantation, and autoimmune disorder management, and is also utilized in clinical research and diagnostic procedures.

The primary categories of leukapheresis devices include therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices. Therapeutic leukapheresis is a medical technique employed to extract surplus or abnormal white blood cells from the bloodstream, aiming to alleviate symptoms or avoid related complications. These systems comprise various elements, including leukapheresis machines, blood collection sets, medical consumables, and filtration components. The diverse group of end users includes hospitals, academic and research organizations, pharmaceutical and biotechnology firms, blood centers, and providers of blood components.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The leukapheresis device market research report is one of a series of new reports from The Business Research Company that provides leukapheresis device market statistics, including the leukapheresis device industry's global market size, regional shares, competitors with the leukapheresis device market share, detailed leukapheresis device market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis device market. This leukapheresis device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis device market size has grown strongly in recent years. It will grow from $0.65 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be credited to the rising demand for personalized medicine, enhanced emphasis on research and development, an increasing number of clinical trials, a growing elderly population, and the expanding adoption of minimally invasive procedures.

The leukapheresis device market size is expected to see strong growth in the next few years. It will grow to $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the rising prevalence of blood-related disorders, increasing incidence of cancer, growing demand for peripheral blood stem cell collection, expanding use of leukapheresis in cellular therapies, and heightened investments in regenerative medicine and immunotherapy. Major trends anticipated during this period include technological innovations in apheresis devices, integration of automation and digital technologies, progress in point-of-care leukapheresis systems, advancements in closed-loop leukapheresis technologies, and technology-enhanced improvements in cell separation efficiency.

The increasing prevalence of blood-related disorders is anticipated to drive the growth of the leukapheresis device market. These disorders affect the structure or function of blood cells, leading to complications with oxygen transport, immune function, and blood clotting. One of the primary reasons for this rise is the aging population, which is more prone to developing conditions such as anemia, leukemia, and other hematologic diseases. Leukapheresis devices play a crucial role in managing these conditions by selectively removing excess or abnormal white blood cells from the bloodstream, thereby easing symptoms and lowering the risk of complications in illnesses like leukemia and autoimmune disorders. For example, in May 2024, the Leukaemia Foundation, an Australian non-profit organization, reported that in 2022, approximately 19,403 Australians were diagnosed with blood cancers, including leukemia, lymphoma, and myeloma. This equates to around 53 new cases each day, or one diagnosis every 27 minutes. Presently, nearly 135,000 Australians are living with a blood cancer or disorder, and projections indicate this number could exceed 275,000 by 2035. This upward trend in blood-related conditions is contributing significantly to the growing demand for leukapheresis devices.

Key players in the leukapheresis device market are increasingly investing in regional production capabilities to improve access to therapeutic devices and align with national healthcare strategies. Establishing local manufacturing facilities helps to streamline supply chains, reduce reliance on imports, and enhance the affordability and availability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, collaborated with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate localized production in Hangzhou. This initiative focuses on producing vital leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely used in China for procedures including therapeutic apheresis, stem cell collection, and blood component separation.

In July 2022, Discovery Life Sciences, a US-based provider of highly characterized human biospecimens, completed the acquisition of AllCells LLC for an undisclosed sum. The acquisition is intended to create a comprehensive, scalable solution offering clients consistent access to high-quality human cellular starting materials along with integrated analytical services to support the development of cell and gene therapies. AllCells LLC, also based in the US, is a biotechnology company that specializes in leukapheresis devices for the targeted collection of blood cells.

Major players in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, and Medica S.p.A.

North America was the largest region in the leukapheresis device market in 2024. The regions covered in leukapheresis device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis device market consists of sales of leukapheresis software and monitoring systems, blood flow controllers and pumps, and centrifuge rotors and tubing sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Therapeutic Leukapheresis; Cytapheresis; Stem Cell Collection; Research Applications; Leukapheresis Columns and Cell Separators; Leukapheresis Disposables; Apheresis Devices
  • 2) By Component: Leukapheresis Machine; Blood Collection Set ; Medical Consumables ; Filters
  • 3) By End User: Hospitals; Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Blood Component Providers; Blood Centers
  • Subsegments:
  • 1) By Therapeutic Leukapheresis: Leukemia Treatment Systems; Sepsis Treatment Leukapheresis Units; Autoimmune Disease Management Devices
  • 2) By Cytapheresis: Plateletpheresis Devices; Lymphapheresis Units; Erythrocytapheresis Systems
  • 3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices; Umbilical Cord Blood Collection Systems; Bone Marrow Stem Cell Apheresis Systems
  • 4) By Research Applications: Cell Separation Systems for Research and Development; Clinical Trial Apheresis Platforms; Academic Laboratory Leukapheresis Devices
  • 5) By Leukapheresis Columns And Cell Separators: Adsorption Columns; Membrane-Based Cell Separation Systems; Centrifugal Cell Separators
  • 6) By Leukapheresis Disposables: Tubing Sets; Needles And Catheters; Collection Bags
  • 7) By Apheresis Devices: Continuous Flow Apheresis Machines; Portable Or Mobile Apheresis Units; Intermittent Flow Apheresis Systems
  • Companies Mentioned: Fresenius SE and Co. KGaA; Asahi Kasei Medical Co. Ltd; Baxter International Inc.; Grifols S.A.; TERUMO BCT INC.; Kaneka Corporation; Charles River Laboratories International Inc.; Mallinckrodt Pharmaceuticals; Nikkiso Co. Ltd.; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma; Precision for Medicine Inc.; B. Braun Melsungen AG; BioIVT LLC; AllCells LLC; Kawasumi Laboratories Inc.; Beijing Zksk Technology Co. Ltd.; Puriblood Medical Co. Ltd; Medica S.p.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukapheresis Device Market Characteristics

3. Leukapheresis Device Market Trends And Strategies

4. Leukapheresis Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Leukapheresis Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Leukapheresis Device Market Growth Rate Analysis
  • 5.4. Global Leukapheresis Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Leukapheresis Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Leukapheresis Device Total Addressable Market (TAM)

6. Leukapheresis Device Market Segmentation

  • 6.1. Global Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Leukapheresis
  • Cytapheresis
  • Stem Cell Collection
  • Research Applications
  • Leukapheresis Columns and Cell Separators
  • Leukapheresis Disposables
  • Apheresis Devices
  • 6.2. Global Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukapheresis Machine
  • Blood Collection Set
  • Medical Consumables
  • Filters
  • 6.3. Global Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Blood Component Providers
  • Blood Centers
  • 6.4. Global Leukapheresis Device Market, Sub-Segmentation Of Therapeutic Leukapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukemia Treatment Systems
  • Sepsis Treatment Leukapheresis Units
  • Autoimmune Disease Management Devices
  • 6.5. Global Leukapheresis Device Market, Sub-Segmentation Of Cytapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plateletpheresis Devices
  • Lymphapheresis Units
  • Erythrocytapheresis Systems
  • 6.6. Global Leukapheresis Device Market, Sub-Segmentation Of Stem Cell Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Blood Stem Cell (Pbsc) Collection Devices
  • Umbilical Cord Blood Collection Systems
  • Bone Marrow Stem Cell Apheresis Systems
  • 6.7. Global Leukapheresis Device Market, Sub-Segmentation Of Research Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Separation Systems For Research And Development
  • Clinical Trial Apheresis Platforms
  • Academic Laboratory Leukapheresis Devices
  • 6.8. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Columns And Cell Separators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adsorption Columns
  • Membrane-Based Cell Separation Systems
  • Centrifugal Cell Separators
  • 6.9. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Disposables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tubing Sets
  • Needles And Catheters
  • Collection Bags
  • 6.10. Global Leukapheresis Device Market, Sub-Segmentation Of Apheresis Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Flow Apheresis Machines
  • Portable Or Mobile Apheresis Units
  • Intermittent Flow Apheresis Systems

7. Leukapheresis Device Market Regional And Country Analysis

  • 7.1. Global Leukapheresis Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Leukapheresis Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Device Market

  • 8.1. Asia-Pacific Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Device Market

  • 9.1. China Leukapheresis Device Market Overview
  • 9.2. China Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Device Market

  • 10.1. India Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Device Market

  • 11.1. Japan Leukapheresis Device Market Overview
  • 11.2. Japan Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Device Market

  • 12.1. Australia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Device Market

  • 13.1. Indonesia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Device Market

  • 14.1. South Korea Leukapheresis Device Market Overview
  • 14.2. South Korea Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Device Market

  • 15.1. Western Europe Leukapheresis Device Market Overview
  • 15.2. Western Europe Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Device Market

  • 16.1. UK Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Device Market

  • 17.1. Germany Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Device Market

  • 18.1. France Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Device Market

  • 19.1. Italy Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Device Market

  • 20.1. Spain Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Device Market

  • 21.1. Eastern Europe Leukapheresis Device Market Overview
  • 21.2. Eastern Europe Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Device Market

  • 22.1. Russia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Device Market

  • 23.1. North America Leukapheresis Device Market Overview
  • 23.2. North America Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Device Market

  • 24.1. USA Leukapheresis Device Market Overview
  • 24.2. USA Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Device Market

  • 25.1. Canada Leukapheresis Device Market Overview
  • 25.2. Canada Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Device Market

  • 26.1. South America Leukapheresis Device Market Overview
  • 26.2. South America Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Device Market

  • 27.1. Brazil Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Device Market

  • 28.1. Middle East Leukapheresis Device Market Overview
  • 28.2. Middle East Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Device Market

  • 29.1. Africa Leukapheresis Device Market Overview
  • 29.2. Africa Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Device Market Competitive Landscape And Company Profiles

  • 30.1. Leukapheresis Device Market Competitive Landscape
  • 30.2. Leukapheresis Device Market Company Profiles
    • 30.2.1. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Device Market Other Major And Innovative Companies

  • 31.1. Kaneka Corporation
  • 31.2. Charles River Laboratories International Inc.
  • 31.3. Mallinckrodt Pharmaceuticals
  • 31.4. Nikkiso Co. Ltd.
  • 31.5. Haemonetics Corporation
  • 31.6. Miltenyi Biotec GmbH
  • 31.7. Macopharma
  • 31.8. Precision for Medicine Inc.
  • 31.9. B. Braun Melsungen AG
  • 31.10. BioIVT LLC
  • 31.11. AllCells LLC
  • 31.12. Kawasumi Laboratories Inc.
  • 31.13. Beijing Zksk Technology Co. Ltd.
  • 31.14. Puriblood Medical Co. Ltd
  • 31.15. Medica S.p.A.

32. Global Leukapheresis Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Device Market

34. Recent Developments In The Leukapheresis Device Market

35. Leukapheresis Device Market High Potential Countries, Segments and Strategies

  • 35.1 Leukapheresis Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Leukapheresis Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Leukapheresis Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer